WOULD YOU LIKE TO
LEARN MORE ABOUT THE THERAPY?

DOWNLOAD THE NEW BROCHURE FOR ALL
INTRATHECAL DRUG DELIVERY (ITDD) INDICATIONs.

  • Reduce Spasticity After Brain Injury
  • Reduce Refractory Cancer Pain
  • Reduce Spasticity In Cerebral Palsy (CP)
  • Reduce Spasticity For Patients With Multiple Sclerosis (MS) 
  • Reduce Spasticity After Spinal Cord Injury
  • Reduce Post-Stroke Spasticity
itdd

*Indicates Required Field

Your information will be processed and protected in accordance with our privacy statement

View our privacy statement

DURABLE DESIGN ENHANCEMENTS

1. Medtronic’s strength is in its scale and extensive real life data. We have implanted over 280,000 SMII pumps globally, have a registry of almost 8,444 patients1 constantly monitored with detailed information (Pumps and SCS), and we analyse  every returned product.

This scale and extensive real life data is the reason we identified 4 product enhancements that aim to improve reliability (survival rate at 7yrs) from 95% to 98%.

2. Which is why Medtronic is constantly striving for better with durable design enhancements, improving reliability by addressing the 3 main causes of motor stalls:

Addressing causes OF MOTOR STALLS2

CAUSES OF
MOTOR STALLS3

59%
SHAFT
WEAR

14%
INTERNAL
SHORTING

2%
CORROSION OF
THE DRIVE GEAR

DURABLE DESIGN
ENHANCEMENTS4

 

APPLIED
DIAMOND-LIKE
CARBON COATING
TO SHAFT

 

ENCAPSULATED
THE
FEEDTHROUGHS

 

MODIFIED THE
GEAR WHEEL
MATERIAL

MEDTRONIC
RESULTS*

 

99%
of shaft wear, addressed4

 

96%
of internal shorting, addressed4

 

93%
corrosion to drive gear, addressed4

GIVING YOU CONFIDENCE PROGRAMMING

SIMPLICITY AND INNOVATION

Wireless Communicator SynchroMed™ II Pump Clinician Programmer; Medtronic provides the latest in programming technology with the SynchroMed™ II Clinician Programmer featuring visuals, workflow guides, a vibrant backlit screen and a wireless communicator to help simplify programming.

Designed to: Be easy to use. Give you confidence. Be modern.

*  Projected performance improvement based on engineering bench (i.e. non-clinical) testing. The implementation of these three design changes does not imply an equivalent percent reduction in motor stall.

1.  Medtronic data on file. PSR 2018. Public report accessible at https://www.medtronic.com/content/dam/medtronic-com/products/product-performance/ppr-reports/2018-TDD-Report.pdf
2.  Medtronic data on file. Proportion Analysis of SynchroMed II PSR Motor Stall c300 Events NDHF1119-166522 v2.0.
3.  Based on all pumps returned and analyzed for motor stalls
4.  Medtronic data on file. The implementation of these three design changes does not imply an equivalent percent reduction in motor stall